| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07391657 A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA)… |
Trial sites expanded: 111 -> 116 locations |
| 2026-06-10 | NCT06530849 A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-10 | NCT06530849 A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus |
Enrollment reduced: 118 -> 20 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07391657 | A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA)… | Relapsed Refractory Multiple Myeloma | Recruiting |
| Phase 1/2 | |||
| NCT06235229 | A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma | Multiple Myeloma | Recruiting |
| NCT07081646 | A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With… | Relapsed AL Amyloidosis | Recruiting |
| NCT05850234 | AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1) | Relapsed/Refractory Multiple Myeloma | Recruiting |
| NCT06897930 | A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With… | Lupus Erythematosus, Systemic | Recruiting |
| NCT06530849 | A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus | Refractory Systemic Lupus Erythematosus | Active, Not Recruiting |
| Phase 1 | |||
| NCT07250269 | Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With… | Relapsed/Refractory AL Amyloidosis | Recruiting |
| NCT07073547 | A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular… | Multiple Myeloma | Recruiting |
| NCT07295847 | A Study of AZD0120 in Autoimmune Diseases | Systemic Sclerosis | Recruiting |
| Early Phase 1 | |||
| NCT07350837 | CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants | Highly Sensitized Patients Awaiting Kidney Transplant | Recruiting |
| NCT05858684 | Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE)… | CAR-T Cell Therapy | Recruiting |